Chennai

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Shanmugapriya.P¹, Thamodharan.S¹, M.Ramamurthy², V.C. Jiji Mol³, M. Nijavizhi^3
1 Department of Nanjunool, National instistute of siddha, Chennai, Tamil Nadu, India
²Assistant medical officer, Salavakkam
³PG scholars, National institute of siddha, Chennai, Tamil Nadu, India
drjijivijay@gmail.com

ABSTRACT
'Gowri chinthamani chendooram', a siddha drug was evaluated for its acute and chronic toxicity studies in wistar albino rats with reference to haematological, bio-chemical and histopathological studies. Acute study revealed a maximum tolerated does of 640 mg/100 gm b.w chronic toxicity study revealed a minimum toxic effect at adoes level of 40 mg/100 gm b.w. Where in, the changes observed were non-specific. The toxicity findings were dose specific, which had tissue damage in higher dosages.

Hospira is the world's leading provider of injectable drugs and infusion technologies. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs.
Through our offering of high-quality, lower-cost generic medications, we continue to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system.

Post: Senior Manager - Production Sterile

Anna University Chennai Regional Office Tiruchirappalli (Formerly Anna University Tiruchirappalli) has been established as a Anna University Chennai Regional Office Tiruchirappalli by the Government of Tamilnadu. The Regional Office is functioning from 01-08-2012 at Tiruchirappalli, which is famously known as Rock Fort city. The Regional Office is situated 17Kms away in the main highway of Tiruchirappalli to Pudukkottai.

Application for the Temporary Post of Project Assistant for the DST, New Delhi Sponsored project in the Department of Pharmaceutical Technology, Anna University, BIT Campus, Tiruchirappalli-620 024, Tamil Nadu.

The objective of the workshop is to give the participants an insight into the world of cancer drug discovery. The intensive sessions will be a perfect blend of theory and practical classes. Apart from the basics of cell culture and cancer biology, the participants will get to know the various marker genes associated with cancer. Gene expression studies with a focus on RT-PCR will be discussed and hands on sessions will ensure that the participants will make the most out of the workshop.

Hospira is the world's leading provider of injectable drugs and infusion technologies. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs.
Through our offering of high-quality, lower-cost generic medications, we continue to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system.

Post: Director - Operations Quality

Hospira is the world's leading provider of injectable drugs and infusion technologies. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs.
Through our offering of high-quality, lower-cost generic medications, we continue to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system.

Post: Assistant Manager - PPIC